Viva Biotech Holdings - Laporan Laba Rugi (TTM)

Viva Biotech Holdings
DE ˙ DB ˙ KYG9390W1015
€ 0.30 0.00 (0.00%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Viva Biotech Holdings menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 538 697 1,111 1,526 1,815 2,104 2,145 2,186 2,283 2,380 2,396 2,413 2,284 2,156 2,075 1,995 1,991 1,987 1,912 1,837
Change (%) 29.64 59.47 37.29 18.95 15.93 1.96 1.92 4.42 4.23 0.70 0.70 -5.34 -5.64 -3.72 -3.86 -0.21 -0.22 -3.77 -3.92
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 293 392 698 1,005 1,229 1,453 1,480 1,507 1,535 1,564 1,550 1,536 1,477 1,417 1,370 1,324 1,311 1,299 1,224 1,149
Change (%) 33.76 78.14 43.86 22.31 18.24 1.84 1.81 1.90 1.86 -0.88 -0.89 -3.88 -4.04 -3.30 -3.41 -0.92 -0.93 -5.78 -6.14
% of Revenue 54.52 56.26 62.84 65.85 67.71 69.06 68.99 68.91 67.25 65.72 64.69 63.67 64.65 65.74 66.03 66.34 65.87 65.40 64.03 62.56
Gross Operating Profit 244 305 413 521 586 651 665 680 748 816 846 877 808 738 705 672 680 687 688 688
Change (%) 24.70 35.45 26.17 12.47 11.09 2.20 2.16 10.00 9.09 3.74 3.60 -7.88 -8.56 -4.52 -4.74 1.18 1.16 0.02 0.02
% of Revenue 45.48 43.74 37.16 34.15 32.29 30.94 31.01 31.09 32.75 34.28 35.31 36.33 35.35 34.26 33.97 33.66 34.13 34.60 35.97 37.44
SG&A 96 123 171 219 271 322 353 385 398 410 413 416 417 418 403 389 379 370 372 374
Change (%) 27.83 38.99 28.05 23.32 18.91 9.84 8.96 3.31 3.21 0.66 0.66 0.22 0.22 -3.48 -3.60 -2.44 -2.50 0.52 0.52
% of Revenue 17.94 17.69 15.41 14.38 14.91 15.29 16.47 17.61 17.42 17.25 17.24 17.24 18.25 19.38 19.43 19.48 19.05 18.61 19.44 20.34
R&D 59 66 74 81 87 92 94 96 116 136 154 172 150 128 111 94 91 88 87 85
Change (%) 12.22 11.47 10.29 6.89 6.45 1.86 1.83 20.88 17.27 13.17 11.64 -12.72 -14.57 -13.24 -15.25 -3.25 -3.35 -1.42 -1.44
% of Revenue 10.95 9.48 6.62 5.32 4.78 4.39 4.39 4.38 5.07 5.71 6.42 7.11 6.56 5.94 5.35 4.72 4.57 4.43 4.54 4.65
OpEx 451 584 946 1,308 1,588 1,867 1,930 1,992 2,053 2,114 2,118 2,123 2,043 1,963 1,887 1,811 1,784 1,757 1,683 1,608
Change (%) 29.57 61.90 38.23 21.38 17.62 3.36 3.25 3.04 2.95 0.22 0.22 -3.77 -3.92 -3.88 -4.04 -1.48 -1.50 -4.24 -4.42
% of Revenue 83.90 83.85 85.13 85.71 87.47 88.74 89.96 91.13 89.93 88.82 88.40 87.98 89.43 91.06 90.91 90.74 89.59 88.44 88.01 87.55
Operating Income 87 113 165 218 227 237 215 194 230 266 278 290 241 193 189 185 207 230 229 229
Change (%) 30.00 46.85 31.90 4.34 4.16 -9.08 -9.99 18.59 15.68 4.53 4.33 -16.79 -20.17 -2.08 -2.12 12.18 10.86 -0.23 -0.23
% of Revenue 16.10 16.15 14.87 14.29 12.53 11.26 10.04 8.87 10.07 11.18 11.60 12.02 10.57 8.94 9.09 9.26 10.41 11.56 11.99 12.45
Interest Expense -51 -62 -91 -120 -151 -183 -180 -176 -180 -185 -184 -184 -180 -177 -148 -120 -87 -54 -47 -41
Change (%) 21.69 46.27 31.63 26.53 20.97 -1.91 -1.95 2.43 2.37 -0.30 -0.30 -1.90 -1.94 -16.04 -19.10 -27.54 -38.00 -11.91 -13.52
% of Revenue -9.50 -8.92 -8.18 -7.84 -8.34 -8.70 -8.37 -8.05 -7.90 -7.76 -7.68 -7.61 -7.88 -8.19 -7.14 -6.01 -4.37 -2.71 -2.48 -2.24
Net Income -349 -387 -79 228 258 288 199 111 -209 -528 -482 -436 -276 -116 -58 -0 83 167 170 172
Change (%) 10.89 -79.52 -388.28 12.94 11.46 -30.64 -44.18 -287.36 153.37 -8.72 -9.56 -36.69 -57.96 -49.86 -99.45 -26,354.09 100.38 1.49 1.47
% of Revenue -64.90 -55.51 -7.13 14.97 14.21 13.67 9.30 5.09 -9.14 -22.21 -20.13 -18.08 -12.09 -5.39 -2.81 -0.02 4.19 8.42 8.88 9.38

Source: Capital IQ

Other Listings
US:VBIZF
HK:1873 HK$ 2.80
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista